Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer. Corso G, Girardi A, Calvello M, Gandini S, et al. Breast Cancer Res Treat 2022 Nov 4. pii: 10.1007/s10549-022-06776.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Corso G, Girardi A, Calvello M, Gandini S, et al. Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer. Breast Cancer Res Treat 2022 Nov 4. pii: 10.1007/s10549-022-06776.
PMID: 36331686